Replacement of fentanyl infusion by enteral methadone decreases the weaning time from mechanical ventilation: a randomized controlled trial

Critical Care

Volumn 16, Issue 2, 2012, Pages

  Wanzuita, Raquel ^a,b   Poli de Figueiredo, Luiz F ^c   Pfuetzenreiter, Felipe ^a,d   Cavalcanti, Alexandre B ^e   Westphal, Glauco A ^a,d  

^a Centro Hospitalar Unimed   (Brazil)

^b Hospital Regional Hans Dieter Schmidt   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Hospital Municipal Sao Jose   (Brazil)

^e Hospital Do Coração   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; METHADONE; PLACEBO; INTRAVENOUS ANESTHETIC AGENT; NARCOTIC ANALGESIC AGENT;

ANALGESIA; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTUBATION; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; TRACHEOSTOMY; TREATMENT DURATION; WITHDRAWAL SYNDROME; ADULT; BRAZIL; HOSPITAL MORTALITY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PROCEDURES; PROSPECTIVE STUDY; TREATMENT OUTCOME; VENTILATOR WEANING;

ADMINISTRATION, ORAL; ADULT; ANALGESICS, OPIOID; ANESTHETICS, INTRAVENOUS; BRAZIL; DOUBLE-BLIND METHOD; FEMALE; FENTANYL; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; METHADONE; MIDDLE AGED; PAIN MANAGEMENT; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VENTILATOR WEANING;

EID: 84858131476     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11250     Document Type: Article

References (33)

1. Novaes MA, Knobel E, Bork AM, Pavao OF, Nogueira-Martins LA, Ferraz MB. Stressors in ICU: perception of the patient, relatives and health care team. Intensive Care Med 1999, 25:1421-1426. 10.1007/s001340051091, 10660851.
2. Puntillo K. Pain experiences of intensive care unit patients. Heart Lung 1990, 19:526-533.
3. Epstein J, Breslow MJ. The stress response of critical illness. Crit Care Clin 1999, 15:17-33, v. 10.1016/S0749-0704(05)70037-3, 9929784.
4. Shapiro B, Warren J, Egol A, Greenbaum D, Jacobi J, Nasraway S, Schein R, Spevetz A, Stone J. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care Medicine. Crit Care Med 1995, 23:1596-1600. 10.1097/00003246-199509000-00021, 7664563.
5. Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, Chalfin DB, Masica MF, Bjerke HS, Coplin WM, Crippen DW, Fuchs BD, Kelleher RM, Marik PE, Nasraway SA, Murray MJ, Peruzzi WT, Lumb PD. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002, 30:119-141. 10.1097/00003246-200201000-00020, 11902253.
6. Payen JF, Chanques G, Mantz J, Hercule C, Auriant I, Leguillou JL, Binhas M, Genty C, Rolland C, Bosson JL. Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology 2007, 106:687-695. quiz 891-682, 10.1097/01.anes.0000264747.09017.da, 17413906.
7. Salluh J, Dal-Pizzol F, Mello P, Friedman G, Silva E, Teles J, Lobo S, Bozza F, Soares M. Delirium recognition and sedation practices in critically ill patients: a survey on the attitudes of 1015 Brazilian critical care physicians. J Crit Care 2009, 24:556-562. 10.1016/j.jcrc.2009.04.004, 19577412.
8. Arnold J, Truog R, Orav E, Scavone J, Hershenson M. Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation. Anesthesiology 1990, 73:1136-1140. 10.1097/00000542-199012000-00011, 2248393.
9. Katz R, Kelly W, Hsi A. Prospective-study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous-infusion. Crit Care Med 1994, 22:763-767. 10.1097/00003246-199405000-00009, 8181283.
10. Cammarano WB, Pittet JF, Weitz S, Schlobohm RM, Marks JD. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med 1998, 26:676-684. 10.1097/00003246-199804000-00015, 9559604.
11. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest 1998, 114:541-548. 10.1378/chest.114.2.541, 9726743.
12. Brook AD, Ahrens TS, Schaiff R, Prentice D, Sherman G, Shannon W, Kollef MH. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999, 27:2609-2615. 10.1097/00003246-199912000-00001, 10628598.
13. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000, 342:1471-1477. 10.1056/NEJM200005183422002, 10816184.
14. Girard TD, Kress JP, Fuchs BD, Thomason JW, Schweickert WD, Pun BT, Taichman DB, Dunn JG, Pohlman AS, Kinniry PA, Jackson JC, Canonico AE, Light RW, Shintani AK, Thompson JL, Gordon SM, Hall JB, Dittus RS, Bernard GR, Ely EW. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008, 371:126-134. 10.1016/S0140-6736(08)60105-1, 18191684.
15. Strøm T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet 2010, 375:475-480. 10.1016/S0140-6736(09)62072-9, 20116842.
16. Anand K, Arnold J. Opioid tolerance and dependence in infants and children. Crit Care Med 1994, 22:334-342. 10.1097/00003246-199402000-00027, 8306694.
17. Gowing L, Ali R, White JM. Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev 2009, CD002025.
18. Gowing L, Farrell M, Ali R, White JM. Alpha2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev 2009, CD002024.
19. Amato L, Davoli M, Minozzi S, Ali R, Ferri M. Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst Rev 2005, CD003409.
20. Honey BL, Benefield RJ, Miller JL, Johnson PN. Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. Ann Pharmacother 2009, 43:1506-1511. 10.1345/aph.1M161, 19690220.
21. Dole V, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. JAMA 1965, 193:646-650. 10.1001/jama.1965.03090080008002, 14321530.
22. Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA 1998, 280:1936-1943. 10.1001/jama.280.22.1936, 9851480.
23. Tobias JD, Schleien CL, Haun SE. Methadone as treatment for iatrogenic narcotic dependency in pediatric intensive-care unit patients. Crit Care Med 1990, 18:1292-1293. 10.1097/00003246-199011000-00024, 1977561.
24. Tobias J, Deshpande J, Gregory D. Outpatient therapy of iatrogenic drug dependency following prolonged sedation in the pediatric intensive care unit. Intensive Care Med 1994, 20:504-507. 10.1007/BF01711905, 7995868.
25. Robertson R, Darsey E, Fortenberry J, Pettignano R, Hartley G. Evaluation of an opiate-weaning protocol using methadone in pediatric intensive care unit patients. Pediatr Crit Care Med 2000, 1:119-123. 10.1097/00130478-200010000-00005, 12813261.
26. Lugo RA, MacLaren R, Cash J, Pribble CG, Vernon DD. Enteral methadone to expedite fentanyl discontinuation and prevent opioid abstinence syndrome in the PICU. Pharmacotherapy 2001, 21:1566-1573. 10.1592/phco.21.20.1566.34471, 11765307.
27. Meyer MM, Berens RJ. Efficacy of an enteral 10-day methadone wean to prevent opioid withdrawal in fentanyl-tolerant pediatric intensive care unit patients. Pediatr Crit Care Med 2001, 2:329-333. 10.1097/00130478-200110000-00009, 12793936.
28. MacIntyre NR, Cook DJ, Ely EW, Epstein SK, Fink JB, Heffner JE, Hess D, Hubmayer RD, Scheinhorn DJ. Evidence-based guidelines for weaning and discontinuing ventilatory support: a collective task force facilitated by the American College of Chest Physicians; the American Association for Respiratory Care; and the American College of Critical Care Medicine. Chest 2001, 120:375S-395S. 10.1378/chest.120.6_suppl.375S, 11742959.
29. Esteban A, Frutos F, Tobin MJ, Alia I, Solsona JF, Valverdu I, Fernandez R, de la Cal MA, Benito S, Tomas R, Carriedo D, Macias S, Blanco J. A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group. New Engl J Med 1995, 332:345-350. 10.1056/NEJM199502093320601, 7823995.
30. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/00003246-198510000-00009, 3928249.
31. Rozendaal F, Spronk P, Snellen F, Schoen A, van Zanten ARH, Foudraine N, Mulder PGH, Bakker J, Ulti SI. Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands. Intensive Care Med 2009, 35:291-298. 10.1007/s00134-008-1328-9, 18949456.
32. Nseir S, Makris D, Mathieu D, Durocher A, Marquette CH. Intensive Care Unit-acquired infection as a side effect of sedation. Crit Care 2010, 14:R30. 10.1186/cc8907, 2887136, 20226064.
33. Breen D, Karabinis A, Malbrain M, Morais R, Albrecht S, Jarnvig IL, Parkinson P, Kirkham AJ. Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial [ISRCTN47583497]. Crit Care 2005, 9:R200-R210. 10.1186/cc3495, 1175879, 15987391.